This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Oncology
Continuous chemotherapy improves outcomes and quality of life in advanced breast cancer
Read more
Raising awareness of brachytherapy: a case study
Read more
World’s first to reproduce complete copy of ‘anti-tumour antibiotic’
Read more
Lynparza approved in EU for germline BRCA-mutated HER2-negative metastatic breast cancer
Read more
ESMO drives EU-level action to tackle shortages of essential medicines
Read more
New treatment combination available first-line to treat advanced kidney cancer
Read more
Cancer Research UK, LifeArc and Ono Pharma form cancer therapy alliance
Read more
Groundbreaking pancreatic cancer trial reaches patient milestone
Read more
Expert analysis: Calling attention to colorectal cancer
Read more
Report exposes deficiencies in the cleanliness and working conditions of oncology units
Read more
NICE recommends Verzenios with an aromatase inhibitor to treat metastatic breast cancer
Read more
New treatment for prostate cancer receives European licence
Read more
Patients to take part in landmark irritable bowel syndrome trial
Read more
The role of NGS in myeloid leukaemia: Part 1
Read more
Realising the full potential of functional genomics
Read more
Inflammatory bowel disease linked to prostate cancer
Read more
Development of new companion diagnostic to guide treatment in advanced breast cancer
Read more
Page 23 of 40
« First
«
...
10
...
21
22
23
24
25
...
30
40
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: